Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blinded Controlled Trial of Alendronate for the Treatment of Childhood and Adolescent Glucocorticoid- Associated Osteopenia and Osteoporosis

NCT00277251 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT00277251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00277251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blinded Controlled Trial of Alendronate for the Treatment of Childhood and Adolescent Glucocorticoid- Associated Osteopenia and Osteoporosis
Lead sponsor
Boston Children's Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2003
Completion date
June 30, 2006
Enrollment
20
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

glucocorticoid-associated osteopenia and osteoporosis